Artem Cherkasov and Olexandr Isayev on Democratizing Drug Discovery with Deep Learning - Ep. 172

Artem Cherkasov and Olexandr Isayev on Democr...

Up next

How Mistral Is Building Frontier AI for the Enterprise | NVIDIA AI Podcast Ep. 301

Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ...  Show more

Everyone Can Build a Robot: Open Source Embodied AI With Seeed Studio | NVIDIA AI Podcast Ep. 300

Seeed Studio is a leader in open source robotics, delivering affordable NVIDIA Jetson‑powered arms that put embodied AI into the hands of millions of makers, students, and small businesses. In this episode, Seeed Studio CEO Eric Pan and Head of Robotics Elaine Wu explain how open ...  Show more

Recommended Episodes

Terry Sejnowski: NeurIPS and the Future of AI
Eye On A.I.

In this episode, Terry Sejnowski, an AI pioneer, chairman of the NeurIPS Foundation, and co-creator of Boltzmann Machines, delves into the latest developments in deep learning and their potential impact on our understanding ...

  Show more

Grant Mitchell — The Potential of AI Drug Repurposing
Infinite Loops

Grant Mitchell is a seasoned entrepreneur, operator, and investor in the areas of health, technology, and machine learning. He is currently the co-founder and CEO of Every Cure, where he uses AI to research rare diseases and conduct drug repurposing.

Grant joins the sho ...

  Show more

From Theory to Therapy: The Evolution of AI in Medicine with Dr. Daphne Koller
NEJM AI Grand Rounds

In this episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care. Initially intrigued ...

  Show more

The Power of Drug Discovery with Philip Tagari
Raising Health

Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.

Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery p ...

  Show more